Dana-Farber Chemical Biology Symposium 2018
Date and time
Location
Jimmy Fund Auditorium
35 Binney St Boston, MA 02215Description
WE ARE AT CAPACITY!
Please add your name to the waiting list if you are interested in attending and we will let you know if space opens up!
We are delighted to welcome you to the inaugural Dana-Farber Cancer Institute (DFCI) Chemical Biology Symposium!
This symposium aims to bring together speakers representing a diverse range of chemical biology research interests, and highlight important insights, developments, and contributions to this unique field. This day-long event is free to attend and open to the public.
Registered attendees are also invited to submit poster abstracts here.
Abstract deadline: August 27, 2018
Lunch is provided for registered attendees!
Keynote speaker: Laura Kiessling, MIT
Speakers:
Hari Arthanari, DFCI
Paola Castaldi, AstraZeneca
Philip Cole, Brigham and Women's Hospital
Cigall Kadoch, DFCI
Derek Lowe, Novartis Institutes for BioMedical Research (NIBR)
Florence Wagner, Broad Institute
Loren Walensky, DFCI
To learn more about this event, email the DFCI Chemical Biology Program at chemical_biology@dfci.harvard.edu, or follow us on Twitter at @DFCI_ChemBio #DFCIChemBio2018
To learn more about Chemical Biology @DFCI visit our website.
Download our event flyer here and spread the word!
See you there!
Organized by
The mission of the Chemical Biology Program is to serve as an intellectual center for cancer chemical biology and small molecule targeting modalities across the Institute, Harvard Medical School, the Dana-Farber/Harvard Cancer Center communities, and beyond. We believe that an accelerated translation of our findings into clinical practice requires a multidisciplinary mindset and team science efforts, and we have extensive and fruitful partnerships with academic, clinical, and industry collaborators.
We aim to be recognized as a global center of chemical biology excellence, and as a model program for translational chemical biology research in cancer, infectious, neurodegenerative, and autoimmune disease areas.